Belgium
Senior healthcare executive driving value creation in complex, global MedTech and Pharma businesses. Proven track record leading large P&Ls, integrating major acquisitions, and guiding organizations through transformation, market expansion, and strategic change. As Executive Vice President, International Commercial Operations, Care Enablement at Fresenius Medical Care, I lead a global commercial organization across five regions, with a mandate to strengthen commercial execution, improve margin and pricing discipline, and accelerate customer and patient impact at scale. I am passionate about healthcare worldwide — shaping market access, driving innovation, and ensuring patients benefit from life-saving therapies.
Strategic Thinking, Go-to-Market Strategy and +3 skills
Charged with developing and implementing the J&J MedTech end-to-end Commercial Excellence strategy, including direct management of the US Key Accounts, Customer operations, Global pricing and Competitive analytics ▪ Implemented an end-to-end J&J MedTech Commercial Excellence strategy, through innovative data strategies and strengthening commercial execution, improving ROI and cashflow. ▪ Increased customer collaboration and improving access for the J&J Med Tech businesses. − Strengthened key stakeholders ‘relationships (IDNs, GPOs, Gov’t accounts) while creating improved access and establishing strategic partnerships. − Advanced portfolio offerings, implemented innovative contracting strategies and accelerated data science capabilities to improve decision making. ▪ Through global competitive insights and strengthening pricing strategy execution, overall J&J MedTech delivered, for the first time in +8 years, price gains.
Responsible for the overall strategy, operations and financial performance of J&J Vision North America. This includes delivering on commercial strategies and managing cross-functional teams while managing P&L accountability. ▪ Transformed the Consumer and Customer experience through innovative digital and channel strategies, delivering within 6 months 3.5pt share growth with partner accounts. ▪ Refocus of product portfolio strategy, incl NPI, recapturing market leadership in premium category ▪ Achieving highest NA overall share since ’17 and highest professional and brand equity score since ’15
Board member J&J Vision, responsible for the integration of acquisitions into the existing business structure with focus on aligning processes, cultures, and strategies to ensure the intended business synergies. ▪ Successful integration of the Abbott Medical Optics into J&J Vision while delivering on the acquisition model. ▪ Acquisition and integration of TearScience, Sightbox.
Managing the J&J Vision Developed Markets (Western Europe) business, as well as leading the EMA Category and Key Account teams and having full P&L accountability. ▪ Shifted organizational focus to acceleration of new product category (presbyopia), driven by customer and market insights and analytics. Resulted in additional +3% growth within 1 year. ▪ Transforming team culture with emphasis on empowerment and competitiveness. Led to market beating performance in ’16 & ’17, with growth 2.5 times category and becoming market leader in ’17. • Turnaround of the UK market, refocusing on key customer and consumer insights and implementing a new go-to-market strategy. Led to accelerated sales growth and returning to share gain for the first time in 3 years.
Leading the business strategies and operations across Latin America for J&J Vision, as well as market development and expansion. Included managing the full regional P&L, building key account partnerships and setting go-to-market strategies. ▪ Accelerated launch of new products while implementing business model innovation in Brazil. Resulted in +10pts of share gain within one year. ▪ Project lead for the global Vision transformation project with aim to accelerate targeted growth opportunities, establish country investment prioritization and develop global marketing and analytics capabilities.
Overseeing the financial strategy for J&J Vision Europe. Responsible for managing budgeting, forecasting, financial reporting, and driving profitability while supporting business growth in the region. ▪ Acquired Russian company, lead due diligence and negotiations. Accelerated growth in Russia to 30% within year. ▪ Implemented EMA investment model/pricing strategy, enabling +10% year on year growth.
• Commercial Director, responsible for procurement, IT and price & contract negotiations with key accounts, government & distributors • As CFO, full P&L responsibility, developing budgets, preparing & evaluating investment plans, all financial & procurement activities • Redesigned & implemented new operating model achieving significant growth in Russia & CIS, while reducing cash flow risk • Exited main distributor with no market disruption or customer impact
Finance Director R&D | Global ChemPharm Development, Discovery EMEA | China & Global Pre-Clinical Research | Controller for Global R&D Spend • Responsible for global finance team supporting J&J Pharmaceutical research & for the consolidation & analytics of global R&D spend outside of the USA • Supported global redesign of all R&D discovery units which led to refocus of capabilities of each discovery unit (eg oncology & pain) and the creation of centres of excellence • Established unique discovery and pre-clinical research unit in China to develop market specific medicines. Played financial lead in negotiations with the Chinese government • Managed a team in the US and Belgium
• Finance director of the Medical Devices plant (Cordis) and the Pharmaceutical production facility (Janssen) • Established lean strategy (Visual Factory) which, after external audit, was recognized to be the leanest plant in J&J EMEA • This, in turn, led to two workshops held with McKinsey & external plants and, subsequently, all pharmaceutical plants were part of a global restructuring • Additionally, responsible for IT, Process Excellence and Procurement
Worldwide Controller J&J Chemical Production | Member of Global Chemical - Board | Financial Controller of all chemical plants within J&J Pharma (USA, Belgium, Ireland, Australia): • Finance lead in successful request to build pilot plant in Belgium • Established new performance management system across all chemical plants